• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 36 of 38
Pfizer employees inside of a laboratory at Pfizer's research and development facility in Cambridge, Massachusetts, U.S., on Monday, Oct. 26, 2015. Photographer: Scott Eisen/Bloomberg *** Local Caption ***
Finance
Why Pfizer Is Headed for Splitsville After Allergan Merger
By Jen WiecznerNovember 19, 2015
Pfizer And AstraZeneca's Billion Dollar Battle
Leadership
A Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By Alan MurrayNovember 19, 2015
Views of The Facebook Inc. Logo Ahead of Earnings
Tech
VW’s New Horror And Facebook 3Q–5 Things To Know Today
By Laura Lorenzetti and Geoffrey SmithNovember 4, 2015
Pfizer And AstraZeneca's Billion Dollar Battle
Finance
Pfizer-Allergan could be a super inversion deal
By Stephen GandelOctober 29, 2015
Inside An Apple Inc. Store As The New iPhones Are Released
Features
Gunboat diplomacy and Apple earnings — 5 things to know today
By Tom Huddleston Jr.October 27, 2015
League Championship Series - New York Mets v Chicago Cubs - Game Four
Features
Apple’s earnings, baseball, and a Fed meeting — 5 things to know this week
By Tom Huddleston Jr.October 25, 2015
CVS/Caremark will no longer cover these drugs, including Viagra
Health
CVS/Caremark will no longer cover these drugs, including Viagra
By Chris MatthewsAugust 7, 2015
Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
Finance
Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
By Tom Huddleston Jr.July 7, 2015
Why America’s patent system is not killing innovation
Commentary
Why America’s patent system is not killing innovation
By David J. KapposMay 8, 2015
FRANCE-RESTAURANTS-BUSINESS-MCDONALDS
Features
McDonald’s hikes pay, and Europe targets Apple, Google — 5 things to know today
By John KellApril 2, 2015
IL: Corporations In Illinois
Finance
Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever
By Jen WiecznerFebruary 6, 2015
President Obama Remarks On Budget At Department Of Homeland Security
Commentary
U.S. corporate tax reform: why Obama’s good ideas don’t add up
By Robert PozenFebruary 5, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Finance
Pfizer to acquire Hospira in a deal worth about $15 billion
By Fortune EditorsFebruary 5, 2015
Earns Pfizer
Features
In speed mode, FDA approves Pfizer’s big new drug early
By Jen WiecznerFebruary 4, 2015
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Zoetis shares spike on reported Ackman stake purchase
By Tom Huddleston Jr.November 11, 2014
1...
  • 34
  • 35
  • 36
  • 37
  • 38
38
Most Popular
Economy
How Scott Bessent used financial engineering to finance the $2 trillion deficit while leaving it untouched—and created a $1.45 trillion shortfallplaceholder alt text
By Eva RoytburgAugust 8, 2026
Real Estate
Meet the 33-year-old CEO betting on boomers chasing their grandkids—and millennials selling their first houseplaceholder alt text
By Nick LichtenbergAugust 8, 2026
Real Estate
The tables have turned: Florida and Texas are the biggest losers in the housing market as Ohio emerges a surprise winnerplaceholder alt text
By Sydney LakeAugust 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.